| Literature DB >> 16144522 |
Ren-Yun Zhang1, Xue-Mei Wang, Sheng-Jin Gong, Nong-Yue He.
Abstract
The study of small drug molecules interacting with nucleic acids is an area of intense research that has particular relevance in our understanding of relative mechanism in chemotherapeutic applications and the association between genetics (including sequence variation) and drug response. In this contribution, we demonstrate how the sequence-specific binding of an anticancer drug Dacarbazine (DTIC) to single base (A-G) mismatch could be sensitively detected by combining electrochemical detection with biosensing surface based on gold nanoparticles.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16144522 PMCID: PMC5172468 DOI: 10.1016/s1672-0229(05)03007-x
Source DB: PubMed Journal: Genomics Proteomics Bioinformatics ISSN: 1672-0229 Impact factor: 7.691
Fig. 1Schematic illustration of electrochemical detection of single A-G mismatch using biosensing surface based on gold nanoparticles.
Fig. 2Cyclic voltammetry of DTIC on bare GCE (a) and ssDNA modified GCE (b), scan rate: 50 mV/s.
Fig. 3Cyclic voltammetry of DTIC on ssDNA modified GCE (a), after hybridization with fully matched sequence (b), and single A-G mismatched sequence (c), scan rate: 50 mV/s.
Fig. 4TEM images of gold nanoparticles (A) and oligonucleotide-modified gold nanoparticles (B).